Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer
| dc.contributor.author | Wu, H. | |
| dc.contributor.author | Sriuranpong, V. | |
| dc.contributor.author | Ponce Aix, S. | |
| dc.contributor.author | Ascierto, P. A. | |
| dc.contributor.author | Fasolo, A. | |
| dc.contributor.author | Sezer, A. | |
| dc.contributor.author | Kowalski, D. M. | |
| dc.contributor.author | Faris, J. E. | |
| dc.contributor.author | Cameron, S. | |
| dc.contributor.author | Mataraza, J. | |
| dc.contributor.author | Garrido Lopez, P. | |
| dc.contributor.author | Antona, V. | |
| dc.contributor.author | Ochoa de Olza, M. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Lin, C-C. | |
| dc.contributor.author | Taylor, M. | |
| dc.contributor.author | Boni, V. | |
| dc.contributor.author | Brunsvig, P. F. | |
| dc.contributor.author | Geater, S. L. | |
| dc.contributor.author | Salvagni, S. | |
| dc.date.accessioned | 2021-03-05T19:40:28Z | |
| dc.date.available | 2021-03-05T19:40:28Z | |
| dc.identifier.citation | Lin C., Taylor M., Boni V., Brunsvig P. F. , Geater S. L. , Salvagni S., Garrido Lopez P., Ozguroglu M., Sriuranpong V., Ponce Aix S., et al., "Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer", 43rd ESMO Congress (ESMO), Munich, Almanya, 19 - 23 Ekim 2018, cilt.29, ss.413 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_d0566ced-1994-47f4-857d-63e180afe56c | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/137745 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Onkoloji | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ONKOLOJİ | |
| dc.title | Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer | |
| dc.type | Bildiri | |
| dc.contributor.department | National Taiwan University , , | |
| dc.identifier.volume | 29 | |
| dc.contributor.firstauthorID | 155102 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]